Cite

    Carmona, L. et al. (2007). All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Annals of the rheumatic diseases. 66 (7), pp. 880-885. [Online].